文書・図像類

Vandetanib (ZD6474), an inhibitor of VEGFR and EGFR signaling, as a novel molecular targeted therapy against cholangiocarcinoma

Icons representing 文書・図像類

Vandetanib (ZD6474), an inhibitor of VEGFR and EGFR signaling, as a novel molecular targeted therapy against cholangiocarcinoma

Material type
文書・図像類
Author
吉川, 大太郎
Publisher
-
Publication date
-
Material Format
Digital
Capacity, size, etc.
-
NDC
-
View All

Notes on use

Note (General):

http://www.ncbi.nlm.nih.gov/pubmed/19319137 | http://www.ncbi.nlm.nih.gov/pubmed/19319137British Journal of Cancer: 100(8):1257–1266text...

Search by Bookstore

Holdings of Libraries in Japan

This page shows libraries in Japan other than the National Diet Library that hold the material.

Please contact your local library for information on how to use materials or whether it is possible to request materials from the holding libraries.

other

  • Asahikawa Medical University Collection and Research

    Digital
    You can check the holdings of institutions and databases with which 学術機関リポジトリデータベース(IRDB)(機関リポジトリ) is linked at the site of 学術機関リポジトリデータベース(IRDB)(機関リポジトリ).

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
文書・図像類
Author/Editor
吉川, 大太郎
Author Heading
Alternative Title
胆道癌に対する新規分子標的治療としてのVEGFR・EGFR阻害剤vandetanib(ZD6474)の検討
Periodical title
学位論文内容の要旨及び審査結果の要旨
Text Language Code
jpn
Target Audience
一般
Note (General)
http://www.ncbi.nlm.nih.gov/pubmed/19319137 | http://www.ncbi.nlm.nih.gov/pubmed/19319137
British Journal of Cancer: 100(8):1257–1266
text
application/pdf
Format (IMT)
application/pdf